Incretin-based therapies and their future in Type 2 diabetes mellitus
Several incretin therapies have been approved by the US FDA and/or
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Several incretin therapies have been approved by the US FDA and/or
Incretin-based therapies, which exploit the physiological actions of GLP‑1, have attracted interest as a novel therapeutic option for Type 2 diabetes. In particular, GLP‑1 receptor agonists provide ... overview of…
impaired insulin secretion, augmented glucagon secretion and reduced b-cell mass. The incretin hormone GLP-1 targets this islet dysfunction. GLP-1 is inactivated by DPP-4 and, consequently ... treatment of hyperglycemia…
without weight gain and hypoglycemia, and preserve b‑cell function. Glucagon-like-peptide-1 (GLP‑1) is known to improve glycemic control by enhancement of glucose-stimulated insulin secretion, preserving ... cell…
streptozotocin (STZ)-induced diabetic rats with respect to glucose, insulin, glucagon-like peptide-1 (GLP-1), C-peptide, glycated hemoglobin (HbAlc), lipid metabolism, and oxidative stress. For this purpose…
time of diagnosis; therefore, we administered steroids and glucagon-like peptide-1 (GLP-1). However, insulin secretion did not recover. Approximately 10 months after onset, her diabetes was under control ... unclear…
The aim of this systematic review is to examine the role of
The first line in the treatment of obesity is a combination of
culture of primary human endothelial and smooth muscle cells to test vascular effects of GLP-1 (7-36) and its degradation products. Local hydrodynamics combined with high glucose and inflammatory ... stimuli affected…
incretin hormone glucagon-like peptide 1 (GLP-1) stimulates insulin biosynthesis and secretion, and inhibits glucagon release in a glucose-dependent manner. However, active GLP-1 is rapidly degraded ... serine protease…
lean which was reversed by SG. DIO caused in an impairment of the GLP-1 but not GIP response to a standard test meal. SG resulted in a dramatic increase ... GLP-1 response to a standard test meal but had no effect on…
useful, is gene therapy. AAV based gene therapy expressing insulin, glucagon-like peptide 1 (GLP-1), extendin-4 and leptin are in progress. Among these insulin based gene therapy ... complicated as this not only…
Objectives : To review the drug treatments and some of the popular , non
This paper describes the differences in food drug administration and European Union
toxicology lots for each of HeV-sG and m102.4 were prepared. A GLP tox study in rats confirmed that m102.4 is safe for Phase 1 clinical studies. A GLP
effect favoured metformin over other treatments (SMD: −0.23, 95% CI [−0.39, −0.07], p = 0.004). GLP-1 receptor agonists and insulin analogues seem to improve BMD compared to placebo, while SGLT2
clinicians in selecting appropriate agents based on patient characteristics. Injectable glucagon-like peptide-1 (glp-1) receptor agonists Injectable GLP-1 receptor agonists represent a significant advancement in…
major global health challenges. Pharmacological interventions, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) including liraglutide and lixisenatide, have shown promise in both weight management and…
such as diabetes, hypertension and hyperlipidemia. Evidence has demonstrated that Diabetes medications such as GLP-1 agonists, such as semaglutide, are gaining a lot of recognition for their weight loss ... carefully…
reversibility and provide insight into biomarkers for clinical monitoring. Good laboratory practice -GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies…
brain neurons. It helps to regulate blood sugar levels by increasing insulin secretion. The GLP-1RAs have been found to lower body weight and improve glycemic indices. These drugs function ... activating GLP-1 receptors…
techniques to measure pharmaceutically produced inorganic elements in bio matrices in support of GLP nonclinical and clinical research. ICP has been utilized in support of Environmental Protection Agency analyses…
reversibility and provide insight into biomarkers for clinical monitoring. Good laboratory practice -GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies…
reversibility and provide insight into biomarkers for clinical monitoring. Good laboratory practice -GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies…
For authors and organisers
Find the right journal for your paper and submit your manuscript.